Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
Cancer Therapy Advisor
8h
Pembrolizumab Improves Upon THP in HER2+ Breast Cancer
Adding pembrolizumab to THP improved pCR rates in patients with HER2-positive breast cancer in the phase 2 NeoHIP trial.
Cancer Therapy Advisor
9h
Paclitaxel and Nab-Paclitaxel Deemed Comparable for High-Risk Early Breast Cancer
Paclitaxel-based and nab-paclitaxel-based chemotherapy produced similar 5-year outcomes in patients with high-risk, HR+, HER2- early breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
SK president impeached
Settle sexual assault suit
US couple killed in Mexico
To end daylight saving time?
Reveals cancer diagnosis
Charged with threatening
$1M to inaugural fund
Trump eyes privatizing USPS
Pelosi undergoes surgery
To hear CA emissions case
Paxton sues New York doctor
UKR targets RU oil facility
Geminid meteor shower
Falsely accused Duke players
Evacuated from Syria
Workers authorize strike
Released by Dolphins
Targeted in bomb threat
US obesity rates drop
First human case in La.
Pearl Harbor survivor dies
14 North Koreans charged
Makes history at BBMAs
GA judge denies motion
Former SC lawmaker dies
DEI official fired
Denied new trial
To settle opioid probe
Bid to delay US ban denied
Bank groups sue CFPB
Ex-Syrian official charged
To lead intelligence board
Defamation suit settlement
US airman sentenced in JP
Renew science agreement
Feedback